Apnea, hypoventilation and pulmonary hypertension: Pathology review

Last updated: November 01, 2022

Apnea, hypoventilation and pulmonary hypertension: Pathology review

Watch later

Watch later

Serotonin and norepinephrine reuptake inhibitors
Monoamine oxidase inhibitors
Typical antipsychotics
Atypical antipsychotics
Lithium
Nonbenzodiazepine anticonvulsants
Anticonvulsants and anxiolytics: Barbiturates
Anticonvulsants and anxiolytics: Benzodiazepines
Psychomotor stimulants
Mood disorders: Clinical
Anxiety disorders: Clinical
Eating disorders: Clinical
Obsessive compulsive disorders: Clinical
Personality disorders: Clinical
Sleep disorders: Clinical
Substance misuse and addiction: Clinical
Somatic symptom disorders: Clinical
Sexual dysfunctions: Clinical
Opioid agonists, mixed agonist-antagonists and partial agonists
Opioid antagonists
Schizophrenia spectrum disorders: Clinical
Dissociative disorders: Clinical
Trauma- and stressor-related disorders: Clinical
Disruptive, impulse-control and conduct disorders: Clinical
Paraphilic disorders: Clinical
Toxidromes: Clinical
Medication overdoses and toxicities: Pathology review
Drug misuse, intoxication and withdrawal: Hallucinogens: Pathology review
Psychiatric emergencies: Pathology review
Potter sequence
Hyperphosphatemia
Hypophosphatemia
Hypernatremia
Hyponatremia
Hypermagnesemia
Hypomagnesemia
Hyperkalemia
Hypokalemia
Hypercalcemia
Hypocalcemia
Renal tubular acidosis
Minimal change disease
Diabetic nephropathy
Focal segmental glomerulosclerosis (NORD)
Amyloidosis
Membranous nephropathy
Lupus nephritis
Poststreptococcal glomerulonephritis
Rapidly progressive glomerulonephritis
IgA nephropathy (NORD)
Alport syndrome
Kidney stones
Hydronephrosis
Acute pyelonephritis
Chronic pyelonephritis
Prerenal azotemia
Renal azotemia
Acute tubular necrosis
Postrenal azotemia
Renal papillary necrosis
Renal cortical necrosis
Chronic kidney disease
Polycystic kidney disease
Multicystic dysplastic kidney
Medullary cystic kidney disease
Medullary sponge kidney
Renal artery stenosis
Renal cell carcinoma
Angiomyolipoma
Nephroblastoma (Wilms tumor)
WAGR syndrome
Beckwith-Wiedemann syndrome
Posterior urethral valves
Hypospadias and epispadias
Vesicoureteral reflux
Bladder exstrophy
Urinary incontinence
Neurogenic bladder
Lower urinary tract infection
Transitional cell carcinoma
Non-urothelial bladder cancers
Congenital renal disorders: Pathology review
Renal tubular defects: Pathology review
Renal tubular acidosis: Pathology review
Acid-base disturbances: Pathology review
Electrolyte disturbances: Pathology review
Renal failure: Pathology review
Nephrotic syndromes: Pathology review
Nephritic syndromes: Pathology review
Urinary incontinence: Pathology review
Urinary tract infections: Pathology review
Kidney stones: Pathology review
Renal and urinary tract masses: Pathology review
Renal system anatomy and physiology
Hydration
Body fluid compartments
Movement of water between body compartments
Renal clearance
Glomerular filtration
TF/Px ratio and TF/Pinulin
Measuring renal plasma flow and renal blood flow
Regulation of renal blood flow
Tubular reabsorption and secretion
Tubular secretion of PAH
Tubular reabsorption of glucose
Urea recycling
Tubular reabsorption and secretion of weak acids and bases
Proximal convoluted tubule
Loop of Henle
Distal convoluted tubule
Renin-angiotensin-aldosterone system
Sodium homeostasis
Potassium homeostasis
Phosphate, calcium and magnesium homeostasis
Osmoregulation
Antidiuretic hormone
Kidney countercurrent multiplication
Free water clearance
Vitamin D
Erythropoietin
Physiologic pH and buffers
Buffering and Henderson-Hasselbalch equation
The role of the kidney in acid-base balance
Acid-base map and compensatory mechanisms
Respiratory acidosis
Metabolic acidosis
Plasma anion gap
Respiratory alkalosis
Metabolic alkalosis
Osmotic diuretics
Carbonic anhydrase inhibitors
Loop diuretics
Thiazide and thiazide-like diuretics
Potassium sparing diuretics
ACE inhibitors, ARBs and direct renin inhibitors
Anatomy of the heart
Anatomy of the coronary circulation
Anatomy clinical correlates: Heart
Anatomy of the superior mediastinum
Anatomy of the inferior mediastinum
Anatomy clinical correlates: Mediastinum
Development of the cardiovascular system
Fetal circulation
Cardiovascular system anatomy and physiology
Lymphatic system anatomy and physiology
Coronary circulation
Blood pressure, blood flow, and resistance
Pressures in the cardiovascular system
Laminar flow and Reynolds number
Resistance to blood flow
Compliance of blood vessels
Control of blood flow circulation
Microcirculation and Starling forces
Measuring cardiac output (Fick principle)
Stroke volume, ejection fraction, and cardiac output
Cardiac contractility
Frank-Starling relationship
Cardiac preload
Cardiac afterload
Law of Laplace
Cardiac and vascular function curves
Altering cardiac and vascular function curves
Cardiac cycle
Cardiac work
Pressure-volume loops
Changes in pressure-volume loops
Physiological changes during exercise
Cardiovascular changes during hemorrhage
Cardiovascular changes during postural change
Normal heart sounds
Abnormal heart sounds
Action potentials in myocytes
Action potentials in pacemaker cells
Excitability and refractory periods
Cardiac excitation-contraction coupling
Cardiac conduction system
Cardiac conduction velocity
ECG basics
ECG rate and rhythm
ECG intervals
ECG QRS transition
ECG axis
ECG normal sinus rhythm
ECG cardiac infarction and ischemia
ECG cardiac hypertrophy and enlargement
Baroreceptors
Chemoreceptors
Arterial disease
Angina pectoris
Stable angina
Unstable angina
Myocardial infarction
Prinzmetal angina
Coronary steal syndrome
Peripheral artery disease
Subclavian steal syndrome
Aneurysms
Aortic dissection
Vasculitis
Behcet's disease
Kawasaki disease
Hypertension
Hypertensive emergency
Coarctation of the aorta
Cushing syndrome
Conn syndrome
Pheochromocytoma
Hypotension
Orthostatic hypotension
Abetalipoproteinemia
Familial hypercholesterolemia
Hypertriglyceridemia
Hyperlipidemia
Chronic venous insufficiency
Thrombophlebitis
Deep vein thrombosis
Lymphedema
Lymphangioma
Shock
Vascular tumors
Human herpesvirus 8 (Kaposi sarcoma)
Angiosarcomas
Persistent truncus arteriosus
Transposition of the great vessels
Total anomalous pulmonary venous return
Tetralogy of Fallot
Hypoplastic left heart syndrome
Patent ductus arteriosus
Ventricular septal defect
Atrial septal defect
Atrial flutter
Atrial fibrillation
Premature atrial contraction
Atrioventricular nodal reentrant tachycardia (AVNRT)
Wolff-Parkinson-White syndrome
Ventricular tachycardia
Brugada syndrome
Premature ventricular contraction
Long QT syndrome and Torsade de pointes
Ventricular fibrillation
Atrioventricular block
Bundle branch block
Pulseless electrical activity
Tricuspid valve disease
Pulmonary valve disease
Mitral valve disease
Aortic valve disease
Dilated cardiomyopathy
Restrictive cardiomyopathy
Hypertrophic cardiomyopathy
Heart failure
Cor pulmonale
Endocarditis
Myocarditis
Rheumatic heart disease
Pericarditis and pericardial effusion
Cardiac tamponade
Dressler syndrome
Cardiac tumors
Acyanotic congenital heart defects: Pathology review
Cyanotic congenital heart defects: Pathology review
Atherosclerosis and arteriosclerosis: Pathology review
Coronary artery disease: Pathology review
Peripheral artery disease: Pathology review
Valvular heart disease: Pathology review
Cardiomyopathies: Pathology review
Heart failure: Pathology review
Supraventricular arrhythmias: Pathology review
Ventricular arrhythmias: Pathology review
Heart blocks: Pathology review
Aortic dissections and aneurysms: Pathology review
Pericardial disease: Pathology review
Endocarditis: Pathology review
Hypertension: Pathology review
Shock: Pathology review
Vasculitis: Pathology review
Cardiac and vascular tumors: Pathology review
Dyslipidemias: Pathology review
Sympatholytics: Alpha-2 agonists
Adrenergic antagonists: Presynaptic
Adrenergic antagonists: Alpha blockers
Adrenergic antagonists: Beta blockers
Calcium channel blockers
cGMP mediated smooth muscle vasodilators
Class I antiarrhythmics: Sodium channel blockers
Class II antiarrhythmics: Beta blockers
Class III antiarrhythmics: Potassium channel blockers
Class IV antiarrhythmics: Calcium channel blockers and others
Lipid-lowering medications: Statins
Lipid-lowering medications: Fibrates
Miscellaneous lipid-lowering medications
Positive inotropic medications
Pulmonary embolism
Pulmonary edema
Pulmonary hypertension
Sleep apnea
Apnea of prematurity
Respiratory distress syndrome: Pathology review
Cystic fibrosis: Pathology review
Pneumonia: Pathology review
Tuberculosis: Pathology review
Deep vein thrombosis and pulmonary embolism: Pathology review
Pleural effusion, pneumothorax, hemothorax and atelectasis: Pathology review
Obstructive lung diseases: Pathology review
Restrictive lung diseases: Pathology review
Apnea, hypoventilation and pulmonary hypertension: Pathology review
Lung cancer and mesothelioma: Pathology review
Antihistamines for allergies
Bronchodilators: Beta 2-agonists and muscarinic antagonists
Bronchodilators: Leukotriene antagonists and methylxanthines
Respiratory system anatomy and physiology
Reading a chest X-ray
Lung volumes and capacities
Anatomic and physiologic dead space
Alveolar surface tension and surfactant
Compliance of lungs and chest wall
Combined pressure-volume curves for the lung and chest wall
Ventilation
Zones of pulmonary blood flow
Regulation of pulmonary blood flow
Pulmonary shunts
Ventilation-perfusion ratios and V/Q mismatch
Breathing cycle
Airflow, pressure, and resistance
Ideal (general) gas law
Boyle's law
Dalton's law
Henry's law
Graham's law
Gas exchange in the lungs, blood and tissues
Diffusion-limited and perfusion-limited gas exchange
Alveolar gas equation
Oxygen binding capacity and oxygen content
Oxygen-hemoglobin dissociation curve
Carbon dioxide transport in blood
Breathing control
Pulmonary chemoreceptors and mechanoreceptors
Pulmonary changes at high altitude and altitude sickness
Pulmonary changes during exercise
Choanal atresia
Laryngomalacia
Allergic rhinitis
Nasal polyps
Upper respiratory tract infection
Sinusitis
Laryngitis
Retropharyngeal and peritonsillar abscesses
Bacterial epiglottitis
Nasopharyngeal carcinoma
Tracheoesophageal fistula
Congenital pulmonary airway malformation
Pulmonary hypoplasia
Neonatal respiratory distress syndrome
Transient tachypnea of the newborn
Meconium aspiration syndrome
Apnea of prematurity
Sudden infant death syndrome
Acute respiratory distress syndrome
Decompression sickness
Cyanide poisoning
Methemoglobinemia
Emphysema
Chronic bronchitis
Asthma
Cystic fibrosis
Bronchiectasis
Alpha 1-antitrypsin deficiency
Restrictive lung diseases
Sarcoidosis
Idiopathic pulmonary fibrosis
Pneumonia
Croup
Bacterial tracheitis
Lung cancer
Pancoast tumor
Superior vena cava syndrome
Pneumothorax
Pleural effusion
Mesothelioma
Pulmonary embolism
Pulmonary edema
Pulmonary hypertension
Sleep apnea
Respiratory distress syndrome: Pathology review
Cystic fibrosis: Pathology review
Pneumonia: Pathology review
Tuberculosis: Pathology review
Deep vein thrombosis and pulmonary embolism: Pathology review
Pleural effusion, pneumothorax, hemothorax and atelectasis: Pathology review
Obstructive lung diseases: Pathology review
Restrictive lung diseases: Pathology review
Apnea, hypoventilation and pulmonary hypertension: Pathology review
Lung cancer and mesothelioma: Pathology review
Glucocorticoids
Protein synthesis inhibitors: Aminoglycosides
Antimetabolites: Sulfonamides and trimethoprim
Antituberculosis medications
Miscellaneous cell wall synthesis inhibitors
Protein synthesis inhibitors: Tetracyclines
Cell wall synthesis inhibitors: Penicillins
Miscellaneous protein synthesis inhibitors
Cell wall synthesis inhibitors: Cephalosporins
DNA synthesis inhibitors: Metronidazole
DNA synthesis inhibitors: Fluoroquinolones
Mechanisms of antibiotic resistance
Integrase and entry inhibitors
Nucleoside reverse transcriptase inhibitors (NRTIs)
Protease inhibitors
Hepatitis medications
Non-nucleoside reverse transcriptase inhibitors (NNRTIs)
Neuraminidase inhibitors
Herpesvirus medications
Azoles
Echinocandins
Miscellaneous antifungal medications
Anthelmintic medications
Antimalarials
Anti-mite and louse medications
Osmotic diuretics
Carbonic anhydrase inhibitors
Loop diuretics
Thiazide and thiazide-like diuretics
Potassium sparing diuretics
ACE inhibitors, ARBs and direct renin inhibitors

Transcript

Watch video only

Joseph, a 42 year old man comes to the clinic because he’s been waking up many times at night, which makes him very sleepy during the day.

His partner also complains that Joseph has always snored but recently it’s louder than ever.

On physical examination he has a BMI of 35 kilograms per square meter, and has a blood pressure of 140 over 90 millimeters of mercury.

You decide to conduct a sleep study, which reveals a very low partial pressure of oxygen.

Later, a 35 year old woman called Robin also comes to the clinic.

She tells you that, lately, she’s been experiencing shortness of breath and fatigue.

Robin is quite worried, and mentions that she has a congenital heart defect.

On physical examination, she has a mean pulmonary arterial pressure of 28 millimeters of mercury.

You decide to perform an electrocardiogram or ECG test, and a chest X-ray, which show that Robin has right ventricular hypertrophy.

Based on the presentation, both cases seem to have some respiratory disease, associated with some cardiovascular issues.

Now, for your exams, some important conditions include sleep apnea, obesity hypoventilation syndrome, and pulmonary hypertension.

So, let’s begin with sleep apnea!

This is when a person, during their sleep, experiences recurrent and intermittent episodes in which they stop breathing for more than 10 seconds.

In addition, since fresh air is not getting into the lungs, individuals with sleep apnea will have nocturnal hypoxia.

This puts the body under stress, which in turn responds by releasing epinephrine.

Now, the recurrent epinephrine surges have several effects.

Firstly, this wakes up the person so that they can breathe again.

This causes disrupted sleep, which in turn leads to somnolence or sleepiness during the day or while awake.

Secondly, the body tries to compensate for the hypoxia by increasing the amount of red blood cells, or erythrocytes, available to carry the oxygen in blood to our tissues.

To do so, our kidneys produce a hormone called erythropoietin, or EPO, which stimulates the bone marrow to produce more red blood cells, and this process is known as erythropoiesis.

The problem with sleep apnea though is that, even if we increase the number of red blood cells, the amount of oxygen that’s entering the body is not enough, so there’s still hypoxia.

Third, having high epinephrine levels can cause vasoconstriction, increasing the vascular resistance.

Over time, this can result in vascular remodeling, which can lead to the development of both pulmonary and systemic hypertension.

Pulmonary hypertension is when the blood pressure in the lung arteries is increased, while systemic hypertension involves the arteries of the rest of the body.

Over time, this can put too much strain on the heart, and ultimately cause abnormal heart rhythms, like atrial fibrillation or atrial flutter, heart failure, and even sudden death.

Diagnosis of sleep apnea involves a sleep study, also known as polysomnography, which counts the number of apnea episodes, and monitors several parameters like heart rhythm and oxygen saturation.

Another important diagnostic value is partial pressure of oxygen in the arteries, since it helps us understand if the tissues are receiving adequate oxygen supply.

This value can be easily and indirectly obtained with a pulse oximeter, or directly obtained via blood gas sampling.

For your exams, remember that people with sleep apnea have low oxygen saturation levels, and thus low partial arterial pressure of oxygen during sleep, but bear in mind that this partial pressure is typically normal when they’re awake.

Now, when the cause of sleep apnea originates in the central nervous system, it’s called central sleep apnea.

Most often though, sleep apnea is caused by an obstruction of airflow in the airways, which is known as obstructive sleep apnea.

And when a person experiences both obstructive and central sleep apnea, it’s called complex or mixed sleep apnea.

Okay, let’s start with central sleep apnea or CSA for short.

Central sleep apnea is caused by an imbalance in the respiratory center of the brain, so during sleep it fails to activate the muscles that control breathing.

The main causes of central sleep apnea include central nervous system injury involving the respiratory center, as well as central nervous system toxicity, often due to use of opioid medications.

Another major risk factor for central sleep apnea is congestive heart failure.

What’s important for your exams is that congestive heart failure leads to increased chemosensitivity, which is how the body senses and responds to changes in the partial pressures of oxygen and carbon dioxide.

So when there’s an apnea episode, oxygen levels decrease while carbon dioxide levels rise.

Now, keep in mind that carbon dioxide is the main stimulus for the respiratory center, so when there are high levels of carbon dioxide, the respiratory center responds by increasing our respiratory rate.

Now, when there’s increased chemosensitivity, the increased CO2 triggers an exaggerated response in the form of hyperventilation, and ends up decreasing the carbon dioxide too much.

So now the CO2 level is too low, and this ultimately causes depression of the respiratory center and thus another apnea episode.

As a result, there’s a vicious cycle that leads to central sleep apnea.

Now, when central sleep apnea is associated with congestive heart failure, it often manifests as an abnormal breathing pattern called Cheyne-Stokes respiration, also known as cyclic respiration.

This is a periodic breathing characterized by oscillation between periods of apnea alternated with deep breaths or hyperpnea.

So, for your exams, remember that the three main things you need to know all start with a ‘C’ for central sleep apnea!

The first is central nervous system injury or toxicity, the second ‘c’ is congestive heart failure, and the third ‘c’ is for- Cheyne-Stokes respiration.

Treatment of central sleep apnea mainly involves positive airway pressure therapy, as well as taking care of the underlying cause.

And then we have obstructive sleep apnea, or OSA for short.

As the name suggests, it is caused by a narrowing or obstruction of the airways.

Now, normally, the airway muscles relax while sleeping

In healthy people though, the airway muscle tone is strong enough to counteract factors that would cause the airway to collapse, such as gravity while lying down, and the negative pressure in the airway during inspiration.

In obstructive sleep apnea, the airway muscle tone is not strong enough to counteract these factors, and so the airway collapses.

In adults, the most common cause is an excess of parapharyngeal tissue, which basically means that there’s excess fat in the neck region.

That’s why obstructive sleep apnea is most common in obese individuals, so those with a BMI over 30 kilograms per square meter.

On a test question, the most important clue suggesting obstructive sleep apnea is loud snoring in an obese individual, like they’re trying to gasp for air until they wake up.

This leads to disrupted sleep, which in turn causes excessive sleepiness during the day or while awake.

Sometimes though, obstructive sleep apnea may affect children; in this case, the most common cause is adenotonsillar hypertrophy, meaning an enlargement of the pharyngeal and palatine tonsils.

Treatment of obstructive sleep apnea involves continuous positive airway pressure, or CPAP therapy, which delivers a steady stream of pressure, in order to keep the airway open.

In addition, weight loss is highly recommended for overweight people.

Finally, one last option is surgery to remove the excess parapharyngeal tissue.

Now, another important respiratory disease that’s very often related to obstructive sleep apnea is obesity hypoventilation syndrome, or OHS for short.

Obesity hypoventilation syndrome is also named Pickwickian syndrome after Charles Dickens’ novel “The Pickwick Papers”, in which there is an overweight character who’s constantly falling asleep at any time of the day.

As the name suggests, obesity hypoventilation syndrome only affects obese individuals.

That’s because the excess weight can restrict the movement of the diaphragm and chest wall, which impairs lung expansion.

As a result, affected individuals develop hypoventilation, meaning slow or shallow breathing.

In most cases, obesity hypoventilation syndrome also causes obstructive sleep apnea and hypoventilation during sleep, but bear in mind that these individuals also experience hypoventilation while awake.

And that’s a high yield fact!

Because of that, diagnosis of obesity hypoventilation syndrome includes an increased partial pressure of carbon dioxide while awake, and while sleeping, they’ll also have a decreased partial pressure of oxygen.

Treatment is mainly focused on weight loss, and some cases can also get positive airway pressure during sleep.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  3. "Pathophysiology of Disease: An Introduction to Clinical Medicine 8E" McGraw-Hill Education / Medical (2018)
  4. "Diagnostic and Statistical Manual of Mental Disorders" A.P. Association and A.P.A.T.F.O.N.A. Statistics (1980)
  5. "Robbins Basic Pathology" Elsevier (2017)
  6. "Sleep Apnoea In The Older Adult" Drugs & Aging (2003)
  7. "Obesity hypoventilation syndrome" European Respiratory Review (2019)
  8. "Pathology of Pulmonary Hypertension" Clinics in Chest Medicine (2007)
  9. "Plexiform Lesions in Pulmonary Arterial Hypertension" The American Journal of Pathology (2011)
  10. "Heart rate and blood pressure responses during hypoxic cycles of a 3-week intermittent hypoxia breathing program in patients at risk for or with mild COPD" International Journal of Chronic Obstructive Pulmonary Disease (2015)
  11. "Cheyne-Stokes respiration in patients with congestive heart failure: causes and consequences" Clinics (2005)
  12. "Congestive Heart Failure and Central Sleep Apnea" Critical Care Clinics (2015)
  13. "Pulmonary hypertension due to lung diseases: Updated recommendations from the Cologne Consensus Conference 2018" International Journal of Cardiology (2018)
  14. "Update on Chronic Thromboembolic Pulmonary Hypertension" Circulation (2014)